ARCHIVES

Bezwoda’s ’95 Phase II Study Entirely A Sham, Audit Finds.

This article is from The Cancer Letter archive.

Vol. 27 No. 17 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

Markison leaving Bristol-Myers, two others promoted in reorganization.

January 30, 2004

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

April 10, 1987

Prevention Clinical Trials Heads Greenwalk Priority Lists For ‘86

February 8, 1985

In Brief: Radiologists Elect Officers, Award Medals; FDA Advisors Okay Test For Breast Cancer

September 29, 1995

ACS Encourages Grant Applications In All Aspects Of Pain Control

May 7, 1993

Cell Phone Radiation Does Not Raise Child’s Risk of Tumors

August 26, 2011